Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
14,339
Total Claims
$1.4M
Drug Cost
538
Beneficiaries
$2,683
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+51%
Opioid rate vs peers
3.9% vs 2.6% avg
+151%
Cost per patient vs peers
$2,683 vs $1,068 avg
+71%
Brand preference vs peers
15.4% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
3.9%
Opioid Rate
559
Opioid Claims
$13K
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 2,189 claims · $1.1M
Generic: 12,062 claims · $365K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 120 | $131K |
| Fluticasone/Umeclidin/Vilanter | 118 | $97K |
| Apixaban | 211 | $80K |
| Empagliflozin | 46 | $59K |
| Pimavanserin Tartrate | 12 | $47K |
| Dapagliflozin Propanediol | 45 | $43K |
| Mirabegron | 86 | $41K |
| Semaglutide | 29 | $40K |
| Rivaroxaban | 86 | $40K |
| Liraglutide | 29 | $39K |
| Dextromethorphan Hbr/Quinidine | 45 | $33K |
| Dulaglutide | 28 | $33K |
| Fluticasone/Vilanterol | 34 | $20K |
| Linaclotide | 16 | $17K |
| Insulin Aspart | 38 | $16K |
Prescribing Profile
Patient Profile
75
Avg Age
63%
Female
1.49
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About